KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Cash from Investing Activities (2016 - 2025)

AbbVie (ABBV) has disclosed Cash from Investing Activities for 14 consecutive years, with -$1.5 billion as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities rose 21.93% to -$1.5 billion in Q4 2025 year-over-year; TTM through Dec 2025 was -$6.6 billion, a 68.09% increase, with the full-year FY2025 number at -$6.6 billion, up 68.09% from a year prior.
  • Cash from Investing Activities was -$1.5 billion for Q4 2025 at AbbVie, up from -$3.3 billion in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $1.3 billion in Q3 2022 to a low of -$9.6 billion in Q1 2024.
  • A 5-year average of -$1.6 billion and a median of -$767.5 million in 2023 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: surged 309.11% in 2022, then tumbled 2137.4% in 2024.
  • AbbVie's Cash from Investing Activities stood at -$1.1 billion in 2021, then surged by 60.87% to -$448.0 million in 2022, then tumbled by 78.57% to -$800.0 million in 2023, then plummeted by 134.25% to -$1.9 billion in 2024, then rose by 21.93% to -$1.5 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Cash from Investing Activities are -$1.5 billion (Q4 2025), -$3.3 billion (Q3 2025), and -$1.2 billion (Q2 2025).